214 related articles for article (PubMed ID: 25247809)
21. Differences in integrin expression and signaling within human breast cancer cells.
Taherian A; Li X; Liu Y; Haas TA
BMC Cancer; 2011 Jul; 11():293. PubMed ID: 21752268
[TBL] [Abstract][Full Text] [Related]
22. Decreased REG1α expression suppresses growth, invasion and angiogenesis of bladder cancer.
Geng J; Fan J; Wang Q; Zhang XP; Kang L; Li QY; Xu YF; Peng B; Zheng JH; Yao XD
Eur J Surg Oncol; 2017 Apr; 43(4):837-846. PubMed ID: 28209239
[TBL] [Abstract][Full Text] [Related]
23. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
[TBL] [Abstract][Full Text] [Related]
24. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.
Luo HB; Li B; Yuan WG; Xu CR
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630
[TBL] [Abstract][Full Text] [Related]
26. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA
Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of TGF-beta receptor I by siRNA suppresses the motility and invasiveness of T24 bladder cancer cells via modulation of integrins and matrix metalloproteinase.
Li Y; Yang K; Mao Q; Zheng X; Kong D; Xie L
Int Urol Nephrol; 2010 Jun; 42(2):315-23. PubMed ID: 19669587
[TBL] [Abstract][Full Text] [Related]
28. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
[TBL] [Abstract][Full Text] [Related]
29. Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer.
Sachs MD; Rauen KA; Ramamurthy M; Dodson JL; De Marzo AM; Putzi MJ; Schoenberg MP; Rodriguez R
Urology; 2002 Sep; 60(3):531-6. PubMed ID: 12350512
[TBL] [Abstract][Full Text] [Related]
30. Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.
Luo BH; Xiong F; Wang JP; Li JH; Zhong M; Liu QL; Luo GQ; Yang XJ; Xiao N; Xie B; Xiao H; Liu RJ; Dong CS; Wang KS; Wen JF
PLoS One; 2014; 9(6):e99922. PubMed ID: 24945379
[TBL] [Abstract][Full Text] [Related]
31. Differential Effects of Integrin
Stojanović N; Dekanić A; Paradžik M; Majhen D; Ferenčak K; Ruščić J; Bardak I; Supina C; Tomicic MT; Christmann M; Osmak M; Ambriović-Ristov A
Mol Pharmacol; 2018 Dec; 94(6):1334-1351. PubMed ID: 30262596
[TBL] [Abstract][Full Text] [Related]
32. CNTO 95, a fully human anti alphav integrin antibody, inhibits cell signaling, migration, invasion, and spontaneous metastasis of human breast cancer cells.
Chen Q; Manning CD; Millar H; McCabe FL; Ferrante C; Sharp C; Shahied-Arruda L; Doshi P; Nakada MT; Anderson GM
Clin Exp Metastasis; 2008; 25(2):139-48. PubMed ID: 18064530
[TBL] [Abstract][Full Text] [Related]
33. Astrocyte elevated gene-1 promotes invasion and epithelial-mesenchymal transition in bladder cancer cells through activation of signal transducer and activator of transcription 3.
Yang X; Shi L; Yi C; Yang Y; Chang L; Song D
Int J Urol; 2018 Feb; 25(2):157-163. PubMed ID: 29117631
[TBL] [Abstract][Full Text] [Related]
34. CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration.
Gong Y; Qiu W; Ning X; Yang X; Liu L; Wang Z; Lin J; Li X; Guo Y
Oncotarget; 2015 Sep; 6(28):25856-67. PubMed ID: 26312564
[TBL] [Abstract][Full Text] [Related]
35. Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition.
Tseng WC; Chuang CW; Yang MH; Pan CC; Tarng DC
Urol Oncol; 2016 Nov; 34(11):485.e15-485.e24. PubMed ID: 27519276
[TBL] [Abstract][Full Text] [Related]
36. Bladder Cancer Metastasis Induced by Chronic Everolimus Application Can Be Counteracted by Sulforaphane In Vitro.
Justin S; Rutz J; Maxeiner S; Chun FK; Juengel E; Blaheta RA
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32759798
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of protein kinase C-alpha in MCF-7 breast cancer cells results in differential regulation and expression of alphavbeta3 and alphavbeta5.
Carey I; Williams CL; Ways DK; Noti JD
Int J Oncol; 1999 Jul; 15(1):127-36. PubMed ID: 10375605
[TBL] [Abstract][Full Text] [Related]
38. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
39. Granulocyte colony-stimulating factor receptor signals for beta1-integrin expression and adhesion in bladder cancer.
Chakraborty A; White SM; Lerner SP
Urology; 2004 Jan; 63(1):177-83. PubMed ID: 14751388
[TBL] [Abstract][Full Text] [Related]
40. Transmigration of human ovarian adenocarcinoma cells through endothelial extracellular matrix involves alphav integrins and the participation of MMP2.
Leroy-Dudal J; Demeilliers C; Gallet O; Pauthe E; Dutoit S; Agniel R; Gauduchon P; Carreiras F
Int J Cancer; 2005 Apr; 114(4):531-43. PubMed ID: 15609323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
